Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

873790

registered interest
date	28/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's mandate to NHS England for 2018-19, published on 20 March 2018, for reasons the elective surgery waiting time of 18 weeks and the emergency waiting time of 4 hours will not be met until 2020.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	134904
answer	answer is ministerial correction date of answer 18/04/2018 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Oxford West and Abingdon (Layla Moran MP) on 28 March 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=133890" target="_blank">133890</a>.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 18/04/2018 14:14:07 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

873791

registered interest
date	28/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's mandate to NHS England for 2018-19, published on 20 March 2018, what plans his Department has to ensure that the elective surgery and emergency waiting times will be maintained at levels set out in previous years' mandates to NHS England.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	134905
answer	answer is ministerial correction date of answer 18/04/2018 answer text <p>The 2018/19 mandate sets out the formal expectation that the National Health Service will meet the agreed constitutional standards on referral to treatment (RTT) and accident and emergency (A&amp;E) waiting times.</p><p> </p><p>The Government expects the NHS to deliver the actions set out in the NHS Planning Guidance for 2018/19 in full as key steps towards fully recovering the performance against these core access standards at the levels they are currently set (RTT 92% and A&amp;E 95%).</p><p> </p><p>We gave the NHS top priority in the 2017 budget with an additional £2.8 billion of funding for the NHS between 2017-18 and 2019-20, and this has been reflected in the mandate. It takes overall funding for the NHS to over half a trillion pounds between 2015 and 2020.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 18/04/2018 14:10:58 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

872243

registered interest
date	26/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Incentives
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of doctors who have been awarded bonuses by clinical commissioning groups limiting the number of patients they refer to hospital; and if he will make a statement.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	134157
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>NHS England confirms that no bonuses have been paid.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/03/2018 13:59:45 answering member 4067 label Biography information for Steve Brine
tabling member	4649 label Biography information for Thelma Walker

872244

registered interest
date	26/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Incentives
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of doctors who have been awarded bonuses by clinical commissioning groups for limiting the number of patients they refer for cancer screening; and if he will make a statement.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	134158
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>NHS England does not hold this information.</p><p> </p><p>NHS England does not support bonus payments to general practitioners for reducing referrals.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/03/2018 13:52:44 answering member 4067 label Biography information for Steve Brine
tabling member	4649 label Biography information for Thelma Walker

865140

registered interest
date	16/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Huddersfield Royal Infirmary
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 March to Question 131949 on Huddersfield Royal Infirmary, on what date the Independent Reconfiguration Panel's report on the potential downgrading of Huddersfield Royal Infirmary will be made public.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	133007
answer	answer is ministerial correction date of answer 21/03/2018 answer text <p>The Joint Chairs of the Calderdale and Kirklees Joint Health Scrutiny wrote to the Department last year formally referring the National Health Service proposal, Right Care Right Time Right Place – Proposed future arrangements for hospital and community health services in Calderdale and Greater Huddersfield. We referred the case to the Independent Reconfiguration Panel in January. An announcement will be made in due course.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 21/03/2018 16:35:07 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

862294

registered interest
date	14/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nabiximols
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 March 2018 to Question 130778 on Nabiximols, what progress his Department has made on reducing the cost of the drug Sativex.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	132713
answer	answer is ministerial correction date of answer 22/03/2018 answer text <p>The Department has had no discussions on reducing the cost of Savitex. The decision to prescribe and fund a licensed treatment on the National Health Service is taken by the relevant clinician and commissioner (such as NHS England or individual clinical commissioning groups) based on the individual needs of the patient.</p><p> </p><p>When the National Institute for Health and Care Excellence (NICE) published its guideline on the treatment of adults with multiple sclerosis (MS) in 2014, it recommended that Sativex should not be offered as an option to treat spasticity in people with MS because it is not a cost effective treatment. NICE is responsible for determining whether its guidance should be updated following the publication of any significant new evidence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/03/2018 17:28:38 answering member 4067 label Biography information for Steve Brine
tabling member	4649 label Biography information for Thelma Walker

860592

registered interest
date	12/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Huddersfield Royal Infirmary
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the Independent Reconfiguration Panels report on the potential downgrading of Huddersfield Royal Infirmary to be made public.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	131949
answer	answer is ministerial correction date of answer 15/03/2018 answer text <p>Last year, the Calderdale and Kirklees Joint Health Scrutiny Committee referred to the Secretary of State the Calderdale Clinical Commissioning Group’s and Greater Huddersfield Clinical Commissioning Group’s proposals entitled “Right Care Right Time Right Place – Proposed future arrangements for hospital and community health services in Calderdale and Greater Huddersfield” under the Local Authority (Public Health, Health and Wellbeing Boards and Health Scrutiny) Regulations 2013. The Secretary of State has asked the Independent Referral Panel for their advice on this matter, and an announcement will be made in due course.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 15/03/2018 14:12:24 answering member 4095 label Biography information for Steve Barclay
tabling member	4649 label Biography information for Thelma Walker

855579

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department has allocated to medical research for the development of new medicines in each of the last three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130886
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The types of biomedical and health related research that are funded by NIHR and other funders can be classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting 'Clinical Trial of an Investigational Medicinal Product (CTIMP)' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is shown in the following table:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:43:10 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855580

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the level of funding from the public purse to be allocated to research for medicines in each of the next three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130887
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The NIHR welcomes funding applications for research into a wide range of areas but does not usually ring-fence funds for particular topics. Awards are made in open competition on the basis of importance of topics to patients and heath and care services, value for money, and scientific quality judged through peer review. The amount of future NIHR funding in specific topic areas will depend on the quality and quantity of research proposals submitted to NIHR for review. As such, NIHR does not hold projected funding allocations specifically for research into medicines.</p><p> </p><p>Information on individual projects funded by the NIHR can be found at:</p><p> </p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p> </p><p>However, NIHR does hold information on previous spend on the types of biomedical and health related research that are funded by NIHR and other funders, classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting ' Clinical Trial of an Investigational Medicinal Product (CTIMP) ' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is set out below:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:36:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855581

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that (a) funding from the public purse for medical research is transparent; and (b) that medicines produced a result of funding from the public purse are affordable.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130888
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The National Institute for Health Research (NIHR) is funded through the Department to improve the health and wealth of the nation through research. Full and open access to the knowledge generated by research is of the utmost importance to the NIHR. The NIHR commitment to transparency, the NIHR Journals Library, open access policy, and endorsement of the World Health Organization joint statement on the disclosure of results ensures that ideas and knowledge derived from publicly funded research are made available and accessible for public use.</p><p> </p><p>The National Institute for Health and Care Excellence technology appraisal guidance and the associated funding requirement plays an important role in ensuring that patients have access to cost-effective new medicines, including medicines developed from public research.</p><p> </p><p>The recent Government and partner bodies response to the Accelerated Access Review sets out how we will work with industry and the health system to create a streamlined and sophisticated approvals system so that cost-effective breakthrough products – be they drugs, devices, digital or diagnostics – can get into the National Health Service as fast as possible.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 13:57:44 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker